Clopidogrel is indicated for the prevention of atherosclerosis events in peripheral arterial disease or within 35 days of myocardial infarction, or within 6 months of ischemic stroke, or (given with aspirin) in acute coronary syndrome without ST-segment-elevation.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
